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Prion proteins can be propagated as amyloid fibrils with several different conformational variants. By
providing structural information at atomic level for two such variants of a yeast prion, Frederick and
colleagues, in this issue of Chemistry & Biology, reveal how conformational flexibility can generate pheno-
typic diversity.Prions are a remarkable subclass of
amyloid proteins associated with poten-
tially infectious brain diseases in mam-
mals, but they also act as novel epigenetic
regulators of a range of cellular functions
in yeast and other fungi. Fungal and
mammalian prions share a common
amyloid core consisting of the character-
istic cross-b molecular architecture that
forms long, unbranched filaments rich in
b sheets. They also share the perplexing
ability to exist as distinct, heritable confor-
mations. In mammals, this conformational
diversity leads to prion strain-specific
neuropathologies, whereas, in the yeast
Saccharomyces cerevisiae, the prion var-
iants can have distinguishable and often
beneficial impacts on the host. What has
been missing until now is an insight into
the structural differences at the atomic
level underlying the prion strains (variants)
and their biological impact. The elegant
paper by Frederick et al. (2014) in this
issue of Chemistry & Biology, addresses
this by using two variants of the yeast
[PSI+] prion.
Although near atomic resolution pic-
tures of the structural organization of the
amyloid core have been obtained for
several types of amyloid fibrils, the link
between amyloid structure and their
varied biological properties and function
has remained elusive (Toyama andWeiss-
man, 2011). Some amyloid assemblies
display a potential for toxic gain-of-func-
tion, whereas others are inert or tolerated
and, as in the case of several different
yeast prions, may even perform beneficial
biological functions. This is also the case
with conformational variants of a given
amyloid that can also generate additional
functional diversity (Newby and Lindquist,
2013). What emerges from the Frederick
et al. (2014) study is a detailed picture172 Chemistry & Biology 21, February 20, 201not only of two distinct conformations of
the amyloid form of Sup35, the underlying
[PSI+] prion protein, but also the dynamic
behavior of these structures. These
findings lead the authors to propose a
plausible mechanism that can explain
why these distinct conformational forms
of Sup35 behave so differently in vivo.
The groundbreaking studies by Weiss-
man and his colleagues (Toyama et al.,
2007) first demonstrated that two variants
of the yeast [PSI+] prion could be distin-
guished by differences in the conforma-
tion of the amyloid core that involves
the N terminus of Sup35 (Figure 1A). The
Sup35 conformations studied were
associated with a ‘‘weak’’ and a ‘‘strong’’
variant of [PSI+] (Figure 1B), so called
because of the difference in the strength
of the prion-associated nonsense sup-
pression phenotype. Remarkably, once a
prion variant conformation is established,
it is faithfully propagated via a two stage
process involving seeded growth of
transmissible prion particles (propagons)
through monomer addition at fibril ends
and the subsequent fragmentation of the
amyloid fibril by the combined action
of three chaperones: Hsp104, Hsp70
(Ssa1), and Hsp40 (Sis1) (Figure 1C).
To explore the conformational distinc-
tions between weak and strong prion
fibrils, Frederick et al. (2014) use solid-
state magic angle spinning nuclear
magnetic resonance (MAS NMR). The
outcome is the first detailed analysis of
the dynamic properties of two different
variants of the amyloid forms of the
[PSI+] prion over a wide range of time-
scales. Although MAS NMR was first
used over a half a century ago, Frederick
et al. (2014) attractively demonstrate the
applicability of this technique to decipher-
ing amyloid properties, thereby enabling a4 ª2014 Elsevier Ltd All rights reservedcomprehensive structural and dynamic
study of these normally refractory mole-
cules in the solid or semi-solid state with
restricted molecular motion. Despite the
global restricted molecular motion that is
prevalent in amyloid fibers, their pioneer-
ing approach reveals critical intramolecu-
lar motion over a wide range of timescales
that highlight rigid and flexible regions in
the two different prion variants of Sup35.
Like the majority of studies to date,
Frederick et al. (2014) focus on the
Sup35NM form of the prion protein lack-
ing the functional C domain (Figure 1A).
The N-terminal region (N) resides within
the amyloid core and is essential
for [PSI+] formation and propagation,
whereas the adjacent and highly charged
region (M) contains a primary binding site
for the Hsp104 chaperone (Helsen and
Glover, 2012). One of their important
findings is that the Sup35NM amyloid
fibrils have both rigid and dynamic re-
gions, with the hitherto relatively confor-
mationally unexplored M region being
highly dynamic in both strong and weak
prion fibrils. Another recent study of the
M region using solid-state NMR has also
suggested that M is a highly flexible re-
gion (Luckgei et al., 2013), which con-
trasts the findings of Shewmaker et al.
(2009), who reported that the M region
forms part of the rigid amyloid core. Using
13C-13C INEPT-TOBSY NMR experi-
ments, Frederick et al. (2014) reveal that
the M region in the weak amyloid fibrils
is 40% more dynamic than in the strong
amyloid fibrils. Furthermore, they show
for the first time that while the N region
lies within distinct but partly overlapping
regions of the rigid amyloid core in
both weak and strong fibers as shown
by others (Toyama et al., 2007; see
Figure 1A), the amyloid core of the two
Figure 1. Biological Implications of theWeak and Strong Variants of
the Yeast [PSI+] Prion
(A) The N and M regions of the prion protein Sup35 are required for the forma-
tion and propagation of the [PSI+] prion. The N region forms the core of the
Sup35 amyloid fibrils. As indicated, the extent of recruitment of the N region
into the amyloid core depends on the [PSI+] prion variant (weak; strong).
The M region is highly charged and contains a primary binding site for
Hsp104. Not shown is the C region, which is required for the function of
Sup35 protein as a translation termination factor.
(B) The phenotypic difference between weak and strong [PSI+] variants is due
to the relative levels of soluble Sup35 in the cells. In a weak [PSI+] variant there
is a relatively high level of functional monomeric Sup35 (spheres) with a
modest impact on translation termination. This reflects an amyloid form
(rods) that is less effectively dismantled by the endogenous chaperone
network driven by Hsp104. Consequently, there are low numbers of high
molecular mass propagons to seed new polymerization of monomeric
Sup35 into the amyloid fibrils. Furthermore, these fibrils are too large to be
efficiently transmitted to daughter cells. By contrast, in the strong [PSI+]
variant, the amyloid fibrils of Sup35 are more amenable to Hsp104-mediated
fragmentation resulting in the generation of more propagons of a lower molec-
ular mass that can be efficiently transmitted to daughter cells. This leads to an
overall reduction in soluble functional forms of Sup35 because of the larger
number of fibril ends available for templating, the net result being a significant
defect in translation termination.
(C) The basic mechanism of propagation of [PSI+] and other yeast prions. The
first stage is seeded polymerization withmonomeric forms of Sup35 binding to
one end of the existing Sup35 amyloid fibrils. As these fibrils are generated,
they are recognized and fragmented by the endogenous chaperone-driven
‘‘disaggregase’’ activity of Hsp104 (shown) in conjunction with two other
chaperones, Hsp70 (Ssa1) and Hsp40 (Sis1) (not shown). The resulting
amyloid fragments can continue to seed new polymerization and constitute
the transmissible ‘‘propagons’’.
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distinct at the conformational
level.
The dynamic, variant-spe-
cific behavior of the Sup35
M region is intriguing. By
showing that this behavior
can modulate the association
between Hsp104 and the
Sup35 fibrils in vivo, Fred-
erick et al. (2014) identify
how the conformational vari-
ability of the amyloid fibril
may influence prion behavior.
In considering this, it is
important to note that pro-
ductive binding of Hsp104 to
Sup35 fibrils in vivo (i.e., lead-
ing to fragmentation) requires
the Hsp70 chaperone Ssa1
to recruit Hsp104 to the fibril
(Winkler et al., 2012). The ef-
fects seen by Frederick et al.
(2014) may therefore reflect
modulation of Ssa1 binding.
Surprisingly the weak fibrils
contain a higher proportion
of tightly bound Hsp104;
but, rather than leading to
increased fibril fragmenta-
tion, it apparently reduces it.
The ability of Hsp104 to bind
nonproductively to Sup35
fibrils via an additional Ssa1-
independent, nonproductive
binding mode has been
recently reported (Winkler
et al., 2012).
How faithfully do the struc-
tural data obtained with
in vitro generated fibrils of
Sup35NM mirror the confor-
mations taken up by either
full-length Sup35 or the con-
formations in the cell? This
concern has been raised by
several studies, e.g., (Luckgei
et al., 2013), but Frederick
et al. (2014) go some way to
address this concern by
studying the structure of
Sup35NM fibrils generatedin vitro using ‘‘natural’’ seeds extracted
from cells. All other structural studies of
[PSI+] variants have employed Sup35NM
fibrils generated in vitro using differenttemperatures of incubation to generate
the different variant-associated forms of
Sup35 (Tanaka et al., 2004). It is also
assumed that for a given [PSI+] variant,Chemistry & Biology 21, February 20, 2014 ª2014 Elseone is studying a homo-
genous collection of fibril
conformations in the cell
extracts used to seed the
in vitro polymerization. How-
ever, recent genetic studies
have indicated that the [PSI+]
prion can potentially exist as
a ‘‘cloud of variants’’ in vivo
(Bateman and Wickner,
2013), and these may
comprise Sup35 structures
in addition to those charac-
terized by Frederick et al.
(2014). The existence ofmulti-
ple conformational variants
for a given prion would greatly
expand the range of pheno-
types a given prion may
generate, be it in relation to
disease states in mammals
or the short-term or long-
term acquisition of new and
beneficial traits in fungi.
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